Media Summary: In the United States, the median price for an Over 6000 different rare diseases identified to date affect 3.5% – 5.9% of the worldwide population. They have a big impact not ... Last week, we argued that the benefits of the

What Is Orphan Drug Status - Detailed Analysis & Overview

In the United States, the median price for an Over 6000 different rare diseases identified to date affect 3.5% – 5.9% of the worldwide population. They have a big impact not ... Last week, we argued that the benefits of the Within the European Joint Programme for Rare diseases, EATRIS and the EMA's Regulatory Science and Innovation Task Force ... Key opinion leaders provide a definition for what is considered a rare disease and the role of the We sat down with Rare Impact Award winner, Desiree Howe, president of the American Porphyria Foundation as she talked about ...

C Russell Teagarden, Senior Vice President, Medical & Scientific Affairs at the National Organization of Rare Disorders (NORD) ... Barry Greene, President and COO of Alnylam Pharmaceuticals explains why Boston and Cambridge are where most Please share this video! We need to and tell Congress not to repeal or alter the Tax Credit, ... Welcome to the PharmaCamp with Neha. This is a small initiative from my side to share knowledge about the It's been three decades since legislation was passed offering incentives for developing therapies for patients suffering from rare ... In this exclusive interview with Rare Disease Report, Ms Divino discusses the study's methods, results, and conclusions.

Paul Melmeyer, Director of Federal Policy, National Organization for Rare Disorders Cartier Esham, Executive Vice President for ...

Photo Gallery

What Is "Orphan Drug Status?"
Orphan Drugs: An Introduction
What are Orphan Medicines? - Video explainer
Orphan Drugs: Costs
How to apply and benefit from an Orphan Drug Designation
FDA Orphan Drugs Program and Financial Incentives for CDER Medical Products- June 10, 2019
Gaming the System: Orphan Drugs Part 3
Defining Rare Diseases and Orphan Drug Act
Orphan Drugs, Exclusivity, and Suing the FDA
The Orphan Drug Machine
How to Obtain Orphan Drug Designation
Orphan Drugs part 4: Fixing the System
View Detailed Profile
What Is "Orphan Drug Status?"

What Is "Orphan Drug Status?"

Find out what "

Orphan Drugs: An Introduction

Orphan Drugs: An Introduction

In the United States, the median price for an

What are Orphan Medicines? - Video explainer

What are Orphan Medicines? - Video explainer

Over 6000 different rare diseases identified to date affect 3.5% – 5.9% of the worldwide population. They have a big impact not ...

Orphan Drugs: Costs

Orphan Drugs: Costs

Last week, we argued that the benefits of the

How to apply and benefit from an Orphan Drug Designation

How to apply and benefit from an Orphan Drug Designation

Within the European Joint Programme for Rare diseases, EATRIS and the EMA's Regulatory Science and Innovation Task Force ...

FDA Orphan Drugs Program and Financial Incentives for CDER Medical Products- June 10, 2019

FDA Orphan Drugs Program and Financial Incentives for CDER Medical Products- June 10, 2019

Roberta Szydlo from FDA's Office of

Gaming the System: Orphan Drugs Part 3

Gaming the System: Orphan Drugs Part 3

This week, we continue our series on

Defining Rare Diseases and Orphan Drug Act

Defining Rare Diseases and Orphan Drug Act

Key opinion leaders provide a definition for what is considered a rare disease and the role of the

Orphan Drugs, Exclusivity, and Suing the FDA

Orphan Drugs, Exclusivity, and Suing the FDA

At NORD's Rare Disease and

The Orphan Drug Machine

The Orphan Drug Machine

The Orphan Drug Machine

How to Obtain Orphan Drug Designation

How to Obtain Orphan Drug Designation

Orphan Drug Designation

Orphan Drugs part 4: Fixing the System

Orphan Drugs part 4: Fixing the System

Drug companies love the

The Orphan Drug Act - How Much Has Changed Since 1983?

The Orphan Drug Act - How Much Has Changed Since 1983?

We sat down with Rare Impact Award winner, Desiree Howe, president of the American Porphyria Foundation as she talked about ...

Orphan Drug Coverage Limits

Orphan Drug Coverage Limits

C Russell Teagarden, Senior Vice President, Medical & Scientific Affairs at the National Organization of Rare Disorders (NORD) ...

Boston,  Cambridge, and Orphan Drug Development

Boston, Cambridge, and Orphan Drug Development

Barry Greene, President and COO of Alnylam Pharmaceuticals explains why Boston and Cambridge are where most

Save the Orphan Drug Tax Credit

Save the Orphan Drug Tax Credit

Please share this video! We need to #SaveOrphanDrugs and tell Congress not to repeal or alter the #OrphanDrug Tax Credit, ...

Orphan Drug Development | Episode  04 - How to get Orphan Drug Designation in European Union | DRA

Orphan Drug Development | Episode 04 - How to get Orphan Drug Designation in European Union | DRA

Welcome to the PharmaCamp with Neha. This is a small initiative from my side to share knowledge about the

Orphan Drug Act 30th anniversary

Orphan Drug Act 30th anniversary

It's been three decades since legislation was passed offering incentives for developing therapies for patients suffering from rare ...

The Annual Cost of Orphan Drugs

The Annual Cost of Orphan Drugs

In this exclusive interview with Rare Disease Report, Ms Divino discusses the study's methods, results, and conclusions.

Paul Melmeyer | Drug Regulation & the Orphan Drug Act

Paul Melmeyer | Drug Regulation & the Orphan Drug Act

Paul Melmeyer, Director of Federal Policy, National Organization for Rare Disorders Cartier Esham, Executive Vice President for ...